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The product of gene(s)  in  the I-J subregion of the mouse H-2  complex that  are 
expressed on allotype-specific and antigen-specific suppressor T cells has been defined 
(1; reviewed in 2). The soluble factors derived from antigen-specific suppressor T cells 
have also been found to bear the I-J subregion gene product  (3-8). However, it has 
not  been determined whether the I-J product on  the antigen-specific suppressor T 
cells is the same as that on the antigen-specific suppressor T  cell factor. Moreover, 
recent studies have shown that conventional anti-I-J alloantisera detect the cell surface 
markers on some helper T cells (9), concanavalin A (Con A)X-induced T cells (10) and 
some antigen-presenting cells (11). Tada et al. (9), especially, have demonstrated that 
the absorption of anti-I-J antisera with Lyt-l-positive splenic T  cells resulted in the 
loss of ability to remove the helper (Th2) T  cell function, whereas the absorbed anti- 
I-J  still  preserved  the  capacity  to  eliminate  the  suppressor  activity.  Thus,  they 
proposed that the I-J product expressed on the antigen-specific suppressor T  cells is 
distinct from that on the helper T  cells.  Therefore, it seems most likely that  two or 
more genes rather than a single gene are accommodated in the l-J subregion. 
A  major difficulty in  the interpretation of the  results  from these experiments as 
mentioned above is  the following:  I-J  products have been detected by alloantisera 
raised by the combination of the intra-H-2 recombinant strains, i.e., B 10.A(3R) and 
B10.A(5R) or BI0.HTT and B10.S(9R) pairs, possibly with an unknown and unequal 
region  in  the  extra-H-2 on  the  17th  chromosomal segment  introduced from either 
parent for raising the recombinant strains.  It is therefore possible that conventional 
anti-I-J alloantisera contain antibodies against the I-J subregion gene products as well 
as the products encoded by genes located somewhere in  the extra-H-2 on the  17th 
chromosome. In fact, previous reports have not formally excluded these possibilities. 
Further experiments are thus required to ascertain whether the/-J-controlled deter- 
minants on the antigen-specific suppressor T  cell are identical to the determinants 
expressed on the antigen-specific suppressor T  cell factors or on other immunocom- 
petent cells with different functional activities. 
It is generally known that/-region-encoded antigens are easily demonstrated on B 
lymphocytes but  detected  with  difficulty on  T  lymphocytes  (reviewed  in  12). I-J 
i Abbreviations used in this paper: C, rabbit complement; Con A, concanavalin A; DNP, 2,4-dinitrophenyl; 
FACS, fluorescence-activated cell sorter;  FCS,  fetal calf serum; HAT, hypoxanthine-aminopterin-thymi- 
dine; KLH,  keyhole limpet hemoeyanin; NS- 1, P3-NSI/l-Ag4-1 ; P3U 1, P3-X63-AgS-U 1; PEG, polyeth- 
ylene glycol;  PFC, plaque-forming cells. 
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products on T  cells are detected mainly by functional studies. For example, anti-I-J 
antisera  are  able  to  eliminate  suppressor  T  lymphocytes but  are  not  detectably 
cytotoxic on unfractionated spleen cells (1), Only a few attempts have been made to 
investigate the existence of I-J products in conventional cytotoxic assays on enriched 
splenic  suppressor T  cells  (13,  14)  and  unfractionated  lymph  node  cells  (15,  16). 
However, direct  demonstration  of I-J  products  on  T  cells  has  not  been  formally 
reported.  This  may  be  due  to  the  difficulty  in  obtaining  high  titers  of anti-I-J 
antibodies and due to the limited expression of I-J products per cell. 
Current  techniques  for  producing  monoclonal  antibodies  by  cell  hybridization 
provide helpful prospects for discriminating between the heterogenous I-J products 
and for defining new products expressed on functionally different immunocompetent 
cells, and also for preparing large quantities of monospecific antibodies. We report 
the establishment  of B  cell hybridomas producing monoclonal anti-I-J  b antibodies 
and describe two types of anti-I-J  b antibodies, one recognizing the private type of I-J  b 
determinant and the other recognizing the cross-reactive determinant between I-ff 
and I-J  d products. Both of the determinants detected by the monoclonal antibodies 
are encoded for by a gene in the I-J subregion. We also demonstrate that the same I- 
J  products are expressed on both antigen-specific suppressor T  cells and their soluble 
factors. Furthermore, by using these monoclonal antibodies, I-J  b products are success- 
fully demonstrated by membrane fluorescence techniques on the I-Jb-positive hybrid- 
oma and on the Con A-induced thymocyte blasts from C57BL/6 mice. 
Materials and Methods 
Animals.  C3H/HeJ (H-2k),  C57BL/6 (H-2b), DBA/2  (H-2a),  and BALB/c (H-2 a)  mice 
were  purchased  from  the  Shizuoka  Experimental  Animal  Co.,  Ltd.,  Shizuoka,  Japan. 
(257BL/10 (H-2~, A/WySn (H-2~), (2BA (H-2k), AKR (H-2k), B10.BR (H-2~), BI0.D2 (H-2d), 
B 10.S (H-2~), B 10.A (2R) (H-2~a), B 10.A(5R) (H-2~, and B 10.A(3R) (H-2 ~) mice were raised 
in our animal facility. (23H.SW (H-2 b) mice were kindly provided by Dr. Okumura, Tokyo 
University, Tokyo, Japan. 
Antigens.  Keyhole limpet hemocyanin (KLH) was  purchased  from (2albiochem-Behring 
Corp., American Hoechst Corp., San Diego, Calif.  Dinitrophenylated KLH (DNP770-KLH) 
was prepared by coupling with 2,4-dinitrobenzensulfonic  acid under alkaline conditions by the 
method of Eisen et al.  (17). Bordetella pertussis vaccine was obtained from the (2hiba  Serum 
Institute, (2hiba, Japan. 
Antibodies.  The monoclonal anti-Thy-l.2 alloantibody (F7D5) was kindly supplied by Dr. 
P.  Lake,  Georgetown University, Bethesda,  Md.  Anti-I-J  b,  B10.A(5R)  anti-B10.A(3R),  and 
anti-I-if, B10.A(3R) anti-Bl0.A(5R) were raised in our laboratory by the reciprocal immuni- 
zation ofthe spleen and thymus cells. Fluorescein-conjugated  rabbit anti-mouse IgG2a antibodies 
were gratefully received from Dr. L. A. Herzenberg, Stanford University,  Stanford, Calif. 
Cell  Lines.  P3-X63-Ag8-U1  (P3U1)  and  P3-NSI/1-Ag4-1  (NS-1),  derived  from  the 
BALB/c myeloma cell line MOP(2-21,  and AKR-derived thymoma BW5147 were obtained 
from Professor Takeshi Watanabe,  Saga Medical  School,  Saga,  Japan.  I-jb-positive  T  cell 
hybridoma lines (348-18, 348-704) with KLH-specific suppressor activity derived from a fusion 
of BW5147 and (257BL/6 KLH-specific suppressor T cells were established  in our laboratory, 
as described elsewhere (8, 18, 19). The T cell lines express the product encoded by a gene in the 
I-J subregion of the major histocompatibility complex. 
Immunization.  B 10.A(3R) spleen and thymus cells were treated with 100 #g/ml ofmitomycin 
(2 (Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan!7 for 45 rain at 37°(2. B10.A(5R) mice were 
repeatedly immunized intravenously with  1 ×  I0  MM(2-treated spleen and thymus cells of 
B10.A(3R) mice at weekly intervals for 7 wk. 
Fusion and Cloning.  3 d after the last immunization, cell hybridization was carried out by the 
modified  method of Oi et al.  (20). In brief,  10  a primed spleen cells of B10.A(5R)  mice were 1292  MONOCLONAL ANTI-I-J ANTIBODIES 
mixed with  1 ×  107  NS-1  or P3U1  plasmacytoma in  a  50-ml  tube  and  pelleted by  light 
centrifugation  at  400  g.  Cells  were  then  resuspended  in  1.0  ml  prewarmed  (37°(])  50% 
polyethylene glycol  (PEG:  4,000  mol/wt;  Sigma  Chemical  Co.,  St  Louis,  Mo.)  by  gentle 
shaking, followed by the dropwise addition of 1 ml of serum-free RPMI  1640  (Gibco Labora- 
tories, Grand Island Biochemical Co., Grand Island, N. Y.).  1 ml of RPMI  1640 medium was 
successively added. The mixture was further diluted with another 7 ml of PRMI  1640. Cells 
were  then  centrifuged  at  200  g  for  5  min  and  were  resuspended  in  warm  hypoxanthine- 
aminopterin-thymidine (HAT)  medium  enriched  with  10%  fetal  calf serum  (F(]S)  (HAT 
medium: RPMI 1640 containing 1 ×  10  -4 M  hypoxanthine, 4 ×  10  -7 M  aminopterin, and  1.6 
×  10  -5 M  thymidine; Wako Pure Chemical Industries, Ltd., Osaka, Japan).  100/xi  of the cell 
suspensions was distributed to each well of a 96-well tissue culture plate (Falcon Labware, Div. 
of Becton, Dickinson & Co., Oxnard, Calif.) Hybrid cells were cultured in HAT medium for at 
least 2-4 wk. Culture supernates of hybrid cells grown in HAT medium were tested for their 
cytotoxic or their binding activity against the  I-Jb-positive T  cell hybridomas. (jells in  the 
positive wells were cloned at least twice with single cell manipulation or limiting dilution. 
Treatment of T  Cell Lines with Neuraminidase.  10 million/ml I-jb-positive T  cell hybridoma 
and BW5147  thymoma cells, which are parental cells for the I-Jb-positive T  cell hybridoma, 
were reacted with 20 btl of neuraminidase (Behringwerke AG, Marburg, West Germany) at a 
concentration of 10 U/ml at 37°(] for 70 min in a CO2 incubator. The treated cells were washed 
and used as target cells for the cytotoxic and cell binding assays. 
Cytotoxic Assay.  A two-step cytotoxic assay was performed. 40,000 target cells and 20/~1 of 
the culture supernates were mixed and incubated for 30 rain on ice in a V-bottomed microtiter 
plate (Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Va.). The cells were washed, 
pelleted, and resuspended in 20 #1 of rabbit complement (C)  at a  1:10 dilution, followed by 
further incubation for 30 rain at  37°(]. Dead and  viable cells were counted under 'the light 
microscope by a trypan blue dye exclusion. The percent cytotoxicity was calculated according 
to the formula: 
percent cytotoxicity -- 100 ×  percent dead experimental -  percent dead C control 
100 -  percent dead C control 
Between 200 and 300 cells were counted per well of the dye exclusion assay. 
Purification of the Monoclonal Antibodies.  Ascites from the hybridoma-bearing mice were pooled, 
dialyzed against 0.01 M sodium phosphate buffer (NaPB), pH 8.0, and passed through a DE52 
cellulose column (Pharmacia Fine Chemicals, Div. of Pharmaeia Inc., Uppsala, Sweden) with 
a continuous gradient buffer (0.01-0.2 M  NaPB). Fractions containing monoclonal antibodies 
that gave a  monoclonal spot by electrophoresis were collected. They were then dialyzed with 
0.01  M  phosphate-buffered saline, pH  7.2, containing 0.1%  NAN3. Myeloma proteins ((]BPC 
101:IgG~) were also purified by the same method as above. 
Radioiodination.  100/~g of affinity-purified rabbit anti-mouse immunoglobulins was mixed 
with 200/LCi of 125I Na in  100 ~1 of phosphate-buffered saline. They were then reacted with 2 
#g of 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril (IODO-GEN;  Pierce Chemical Co., Rock- 
ford, Ill.) in a glass tube for 10 min on ice. The reaction mixture was then applied to 10 ml of 
the Bio-Gel P-6 column (Bio-Rad Laboratories, Richmond, Calif.) to remove free iodine. 
Quantitative Absorption of  Monoclonal Antibodies with Cells.  100 #1 of  the diluted culture supernate 
from the cloned hybridoma that gave the end point of the maximum cytotoxicity was absorbed 
with  graded numbers  of spleen cells from  various strains of mice at  4°C  for 60  min,  with 
occasional shaking.  They  were  then  centrifuged,  and  the  supernate  was  further  tested  for 
b  residual cytotoxic activity against neuraminidase-treated I-J -positive hybridoma cells (34S-18). 
Enrichment of KLH-specific  Suppressor T  Cells.  KLH-specific suppressor T  cells from primed 
spleen cells of (]57BL/6,  BALB/c, or C3H  mice were enriched by using KLH-coated petri 
dishes, as described previously (14).  Briefly, spleen cells of (]57BL/6, BALB/c, or C3H  mice 
immunized twice with 200 #g of KLH at 2-wk intervals were applied to and incubated for 1 h 
on petri dishes coated with rabbit anti-mouse immunoglobulins at room temperature to remove 
B cells. Nonadherent cells that usually contain >95% T cells were further incubated with KLH- 
coated petri dishes under the same conditions as above. The cells that bound to KLH-coated 
dishes were recovered by the temperature shift (on ice) and pipetting with cold (4°C) medium. KANNO ET AL.  1293 
The antigen-binding cells  thus obtained were usually 0.1-0.5%  of the unfractionated spleen 
cells. 
Preparation oflmmunoadsorbent Columns.  Approximately 5 mg of monoclonal antibodies in  1 
ml of ascites  from the hybridoma-bearing mice was precipitated with ammonium sulfate at a 
concentration of 50%. They were extensively dialyzed with phosphate-buffered saline and were 
conjugated with  1 ml of Sepharose 4B (Pharmaeia Fine Chemicals) by the method of Axen et 
al.  (21). 
Absorption and Elution of the Monoclonal I-Jb-bearing Suppressor Factor with Columns.  The extracted 
materials equivalent to 3 ×  105 I-Jb-positive hybridoma cells  (34S-18 or 34S-704)  were passed 
through immunoadsorbent columns. After extensive washing with RPMI  1640, the absorbed 
materials were eluted with 0.175 M  glyeine-HCl buffer, pH 3.2. The effluent and eluate were 
both tested for their activity in the in vitro secondary antibody response, as described elsewhere 
(22). 
Fluorescent Stainings.  1 million of the neuraminidase-treated  I-Jb-positive T  cell hybridoma 
cells  (34S-704)  in  100 #1 of Dulbeceo's modified minimal essential  medium containing 0.1% 
NaN3  were  reacted  with  10  #g  of purified  monoclonal  antibodies  El0  (IgG~)  at  room 
temperature  for 30  min.  The  cells  were  washed  twice  and  then  stained  with  fluorescein- 
conjugated rabbit anti-mouse IgG2~ at room temperature for 30 min. 10 #g of purified myeloma 
protein (CBPC  101: IgG~) were used as control for the stainings. The stained cells were then 
analyzed  in  a  fluorescence-activated  cell  sorter  (FACS  IV;  B-D  FACS  Systems,  Beckton, 
Dickinson & Co., Sunnyvale, Calif.).  Con A-induced thymocyte blasts were also used as target 
cells for a  fluorescent-staining analysis.  10 million/ml thymocytes from C57BL/6 (H-2~  and 
C3H (H-2~ were cultured with 5 #g/ml of Con A (Sigma Chemical Co) for 48 h at 37°C in a 
CO2 incubator. The cells were harvested and then extensively washed with medium.  1 million 
of the live cells fractionated by Ficoll-Conrey (Pharmacia Fine Chemicals) were reacted with  1 
#g of purified monoclonal anti-I-J  b antibodies (El0 or H6: IgG~) or myeloma protein (CBPC 
101: IgG2a) followed by staining with fluorescein-conjugated rabbit anti-mouse IgG~ antibodies. 
Approximately 20% of Con A-treated thymocytes, which are large blast cells, were analyzed by 
FACS-IV. 
Cell Culture.  4 million spleen cells of C57BL/6 mice immunized 4 wk previously with  100 
#g of DNP-KLH and Bordelella pertussis vaccine were cultured in the presence of 0.1 #g DNP- 
KLH in the Mishell-Dutton system. The materials from the immunoadsorbent columns were 
added to the culture at the start of cultivation. 5 d later, anti-DNP plaque-forming cells (PFC) 
were enumerated by using DNP-coupled sheep erythrocytes. 
Results 
Production of Anti-I-J b Monoclonal  Antibodies.  The monoclonal antibodies  D7,  El0, 
F4, D4, and H6 were selected from the products of the fusion of mouse myeloma cells 
(P3U 1 or NS-1) with spleen cells of B 10.A(5R) mice hyperimmunized with mitomycin 
C-treated spleen and thymus cells of B10.A(3R)  mice. Fused cells were plated in 0.2- 
ml  tissue  culture  wells  and  cultured  in  HAT  medium  for  at  least  2-4  wk.  The 
supernatant  fluids  were  then  harvested  and  assayed  for  their  antibody  activities 
against  the products encoded by genes in the I-J b subregion of the H-2 complex by 
using a  cell-binding assay with  radioiodinated  rabbit  anti-mouse  immunoglobulins. 
For screening the  anti-I-Jb-producing hybridomas,  several  T  cell  hybridomas  (lines 
34S-18, 34S-704)  with antigen-specific suppressor activities were used as target cells. 
AKR-derived T  lymphoma cells, BW5147, which are parental  cells of T  cell  hybri- 
domas, were utilized as control target cells.  The T  cell hybridomas used express the 
products of genes in the I-J subregion, as described elsewhere  (8,  18,  19).  All positive 
supernatant  fluids were further examined by a  C-dependent  cytotoxic assay. 
The D7 and  D4 antibodies  were shown to be serologically IgM, and the El0,  F4, 
and H6 antibodies were IgG2a, IgG~b, and IgG2a, respectively.  Fig.  1 shows cytotoxic 
patterns  of the  conventional  anti-I-J  b  antiserum  [B10.A(5R)  anti-B10.A(3R)],  the 1294  MONOCLONAL ANTI-I-J ANTIBODIES 
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FIO.  1.  Cytotoxic curves of anti-l-J  b antibodies on the I-Jb-positive T cell hybridoma (34S-18) or 
on the parental T lymphoma cell line, BW5147, of the T cell hybrids. The cytotoxicity of BI0.A(5R) 
anti-Bl0.A(3R)  (A, &), culture supernates  (El0)  ([~, 1), and ascitie fluid from the hybridoma 
(El0)-bearing mice (C), 0) was investigated by dye exclusion eytotoxic assays. Target cells were 
pretreated with neuraminidase  (see Materials and Methods). Other monoclonal antibodies (D7, F4, 
H6, and D4) gave results similar to the El0 antibody. The open and closed symbols indicate the 
cytotoxic titers on the l-Jb-positive hybridoma (A, I--I,  ©) and on BW5147 (&, l, e), respectively. 
The background in these experiments was < 10%. 
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Fro. 2.  Cytotoxic  activities  of the  monoclonal  antibodies  El0  and  H6  on  the  KLH-specifie 
suppressor T ceils from C57BL/6 (H-2~ (a), C3H (H-2*) Co),  and BALB/c (H-2  a) (c) mice enriched 
with KLH-coated petri dishes. 4 X 104 enriched cells were treated with monoclonal anti-Thy-l.2 
(O), BI0.A(SR) anti-Bl0.A(3R)  (O), B10.A(3R) anti-Bl0.A(SR)  (&), or monoelonal antibodies El0 
(f"l) and H6 (A), as described in Materials and Methods. The background in these experiments was 
<5%. 
culture supernate, and the ascitic fluid from the mice bearing the hybridoma  (El0) 
on  the  I-jb-positive suppressor  T  cell  hybridoma  (34S-18).  Conventional  anti-I-J  b 
antiserum showed low titers of cytotoxic activity on the I-Jb-positive T  cell hybridoma. 
However, high titers of cytotoxic activity were obtained by the ascitic fluid and the 
culture supernate.  No cytotoxic activity was observed on  the BW5147  cells. Similar 
results were obtained by other monoclonal antibodies (D4, D7, F4, and H6). 
Cytotoxic  Activity  on  the  Antigen-specific  Suppressor  T  Cells.  The  reactivity  of  the 
monoclonal antibodies D7,  El0,  F4, D4,  and  H6 was  investigated by dye exclusion 
cytotoxic assay on KLH-primed splenic suppressor T  cells of C57BL/6  (H-2b),  C3H 
(H-2k),  and  BALB/c  (H-2 a)  mice  enriched  with  KLH-coated  petri  dishes.  The 
methods to enrich I-J-positive splenic suppressor T  cells were described elsewhere (14). KANNO  ET  AL.  1295 
The suppressor activity of the enriched cells thus obtained has usually been shown to 
be >100-fold as much as that of unfractionated spleen cells  (14).  As shown in Fig. 
2 a-c, -80% of the cells enriched from C57BL/6, C3H, or BALB/c mice were Thy-1- 
positive T  cells.  In addition, ~50% of the cells from C57BL/6 mice were susceptible 
to conventional anti-I-J  b but  not  to anti-I-J  k antisera.  Similarly, anti-I-J  k antisera 
killed  -50%  of C3H  but  not  C57BL/6-enriched  T  cells.  Therefore, enriched  cell 
populations from each strain of mice contain ~50% I-J-positive cells. Thus, we used 
these I-J-positive suppressor T  cells as target cells to determine the reactivity of the 
monoclonal antibodies. 
All of the monoclonal antibodies tested killed ~50% of the enriched suppressor T 
cells from C57BL/6, although no cytotoxic activity was observed on those from C3H 
mice. It is clear that the monoclonal antibodies recognize antigen-specific suppressor 
T  cells expressing I-J  b products. However, Fig. 2 also demonstrates that some of the 
monoclonal antibodies revealed cross-reactive cytotoxic activity on the H-2 a suppres- 
sor T  cells  because  -30%  of BALB/c-derived enriched T  cells were  lysed by the 
monoclonal H6 but not by the El0 antibodies. The cross-reactivity was also observed 
by  the  D4  antibody but  was  not  detected  by  the  conventional  anti-I-J  b antisera 
[B 10.A(5R) anti-B 10.A(3R)] nor by other monoclonal antibodies (D7 and F4)  (some 
data not shown). 
Genetic Specificity of Monoclonal Antibodies.  To demonstrate the genetic specificity of 
monoclonal  antibodies  D7,  F4,  El0,  H6,  and  D4,  100  ~tl  of the  diluted  culture 
supernates of the clones that  gave the end point of the maximum cytotoxicity was 
absorbed  with  graded  numbers  of spleen  cells  from  various  strains  of mice.  The 
residual cytotoxic activity was tested on the I-jb-positive hybridoma (34S-18). Fig. 3 a 
and b shows the cytotoxic curves of the monoclonal antibodies El0 (Fig. 3a) and H6 
(Fig. 3b) before or after absorption with spleen cells from B10.BR (H-2k), B10.S (H- 
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FIG.  3.  Quantitative  absorption  analysis of the monoclonal antibodies El0  and  H6.  100 /xl  of 
culture supernates from the El0 clone (a) at a  1:2,000  dilution and the same amount from the H6 
clone (b) at  a  1:3,000  dilution were absorbed with twofold dilution of the following spleen cells: 
C57BL/6 (11-2  b) (O), C57BL/t0 (H-2~  (&), C3H.SW (H-2~  (11), BI0.S (H-2") (O), C3H (H-2~ 
(I-I), B10.D2 (H-2  a) (X), and BI0.BR (H-2  k) (A). The residual cytotoxic activity was assayed on the 
neuraminidase-treated I-jb-positive T  cell hybridoma  (34S-18).  The background  was <20%  (see 
Materials and Methods). ~o 
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FIo. 4.  Quantitative absorption analysis of the monoclonal antibodies El0 and H6.  100 #1 of 
culture supernates from the El0 clone (a) at a 1:2,000 dilution and the same amount from the H6 
clone (b) at a  l:3,000 dilution were absorbed with twofold dilution of the following spleen cells: 
C57BL/10 (H-2  b) (A), B10.A(3R) (H-2  ~) (O), B10.A(2R)(H-2  ^2) (A), B10.A(5R) (H-2  ~5) (©), and 
A/WySn (H-2") (I-I).  The residual cytotoxic  activity was assayed as in Fig. 3. The background was 
<20%. 
(H-2t'). The cytotoxic activity of the E 10 and H6 antibodies was absorbed with spleen 
cells of C57BL/6, C57BL/10, and C3H.SW having H-2  b haplotype. The reactivity of 
the monoclonal antibodies  was preserved, however, even when  the antibodies were 
absorbed  with  2  ×  107  spleen  cells  of BI0.BR,  B10.S,  and  C3H  mice.  Therefore, 
absorption  with Ho2 °  spleen  cells always removed the antibody activity.  However, 
when  the antibodies were absorbed with  2  ×  106 to 20  ×  106 of B10.D2  D2  (H-2 a) 
spleen cells, the reactivity of the H6 but not El0 antibody was abrogated. The same 
results on the cross-reactivity between H-2 b and H-2 a spleen cells were obtained with 
the D4 but not with the F4 and D7 antibodies. These data in Fig. 3 a and b suggested 
that the monoclonal antibodies are directed against the H-2 b gene products and that 
the H6 and D4 antibodies possessed the cross-reactivity to the H-2  d products. 
The I-J specificity of monoclonal antibodies was further characterized. The recom- 
binants,  B10.A(5R)  and B10.A(3R),  which were raised during back-crosses between 
C57BL/10  and  A/WySn,  might  have  the  unequal  chromosomal  segment  from 
A/WySn  on  the  17th  chromosome  of  C57BL/10  mice.  The  immunization  of 
B10.A(5R) with B10.A(3R)  is possible to make antibodies to the I-J  b products as well 
as those against the unknown  products encoded by genes located somewhere in the 
right  side  end  of the  extra-H-2 on  the  chromosomal  segment  from  C57BL/10  or 
A/WySn.  To exclude  the  reactivity against  the  unknown  products,  the  antibodies 
were absorbed with spleen cells of C57BL/10, B 10.A(3R), B 10.A(5R), B 10.A(2R), or 
A/WySn. As shown in Fig. 4 a  and b, the cytotoxicity of the monoclonal antibodies 
with  cross-reactive  (H6)  or  noncross-reactive  activities  (El0)  were  abrogated  by 
absorption with C57BL/10 and B 10.A(3R)  but not with B 10.A(5R), B 10.A(2R), and 
A/WySn.  The same results were obtained by other monoclonal antibodies  (D4, F4, 
and D7). It is therefore concluded that the monoclonal antibodies are specific for the 
l-J b subregion gene products. 
Cross-reactivity of the H6 and D4 Antibodies.  To confirm the previous results showing 
the  cross-reactivity  between  I-J  b  and  I-J  d  products  detected  by  the  H6  and  D4 
antibodies, quantitative absorption analysis of the cross-reactive antibody  (H6)  was KANNO  ET  AL.  1297 
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Fzc.  5.  Quantitative  absorption  analysis of the  monoclonal  antibodies  El0  and  H6.  100  /xl of 
culture supernates from the El0 clone (a)  at a  1:2,000 dilution and the same amount from the H6 
clone  (b)  at  a  l:3,000 dilution were absorbed with twofold dilution of the following spleen cells: 
C57BL/10 (H-2  b) (A), BALB/c (H-2  d) (A), DBA/2 (H-2  a) (O), B10.D2 (H-2  d) (×),  and BI0.BR 
(Ho2  k) (0). The residual cytotoxic activity was assayed as in Fig. 3. The background was <20%. 
TABLE  I 
Cytotoxicity of Monoclonal Antibodies after Absorption with Spleen Cells  from Various 
Strains of Mice 
Absorption 
with* 
tt-2 complex  Percent cytotoxlcity of the ab- 
sorbed monoclonal antibodies 
K  A  B  J  E  C  S  D  El0  F4  D7  H6  D4 
None  --  63  59  65  71  63 
C57BL/10  b  b  b  b  b  b  b  b  <5  <5  <5  <5  <5 
C57BL/6  b  b  b  b  b  b  b  b  <5  --:~  --  <5  <5 
BI0.S  s  s  s  s  s  s  s  s  58  49  59  54  69 
B10.BR  k  k  k  k  k  k  k  k  52  51  68  63  69 
CBA  k  k  k  k  k  k  k  k  --  --  68 
AKR  k  k  k  k  k  k  k  k  66  53  65  59  67 
C3H  k  k  k  k  k  k  k  k  55  55  --  63  65 
C3H.SW  b  b  b  b  b  b  b  b  <5  --  --  <5  <5 
B10.A(3R)  b  b  b  b  k  d  d  d  <5  <5  <5  <5  <5 
B10.A(5R)  b  b  b  k  k  d  d  d  56  54  68  59  61 
A/WySn  k  k  k  k  k  d  d  d  57  60  60  58  54 
B10.A(2R)  k  k  k  k  k  d  d  b  53  62  65  67  62 
BALB/c  d  d  d  d  d  d  d  d  59  58  --  <5  <5 
DBA/2  d  d  d  d  d  d  d  d  56  61  60  <5  <5 
B10.D2  d  d  d  d  d  d  d  d  53  --  63  <5  <5 
* 100 pJ of culture supernates from the E 10 clone at a  1:2,000 dilution, from the F4 clone at 
a  1:2,000 dilution, from the D7 clone at a  1:500 dilution, from the H6 clone at a  1:3,000 
dilution, and from the D4 clone at a  1:800 dilution were absorbed with 2 ×  107 spleen cells 
of various strains of mice. The residual cytotoxic activities of the absorbed antibodies were 
tested on the neuraminidase-treated I-J%positive hybridoma cells (34S-18). 
:~ Not done. 
carried  out  by  using  various  H-2 a  spleen  cells  (BALB/c,  B10.D2,  and  DBA/2)  in 
comparison  with  the noneross-reactive  antibodies  (El0).  The  results are shown  in Fig. 
5  a  and  b. The  spleen  cells from  BALB/c,  B 10.D2, and  DBA/2  mice  show  the capacity 
to  absorb  the  cytotoxic  activity  of  the  H6  but  not  El0  antibodies,  although  no 1298  MONOCLONAL  ANTI-I-J  ANTIBODIES 
TABLE  II 
Absorption of KLH-specific Hybridoma-derived Suppressor Factor with 
Monoclonal Anti-l-J b Antibodies 
Anti-DNP IgG  TsF absorbed with*  Materials added  PFC/culture~: 
None  None  4,650 ±  660 
None  Unabsorbed TsF  1,490 ±  320 
NMS  Effluent  1,650:1:550 
Eluate  5,280 ±  670 
F4  Effluent  4,240 ±  470 
Eluate  1,340 + 430 
El0  Effluent  4,300 ±  510 
Eluate  1,820 ±  310 
D7  Effluent  4,080 :t: 420 
Eluate  1,610 ±  380 
H6  Effluent  6,360 ±  750 
Eluate  1,960 ±  750 
D4  Effluent  4,250 ±  190 
Eluate  1,230 +  390 
* The  extract  of the  KLH-specific suppressor T  cell  hybridoma  (34S-18) 
equivalent to 5 X l0  s cells was absorbed to and eluted from immunoadsorbent 
columns composed of monoclonal antibodies (F4, El0, D7, H6, and D4) or 
normal mouse serum (NMS). The effluent and the eluate from the columns 
were tested for their activity in the in vitro secondary anti-DNP IgG  PFC 
response (see Materials and Methods). TsF is T suppressor  factor. 
:~ The arithmetic means of PFC numbers of three cultures :l: standard devia- 
tions. 
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absorption was observed with  B10.BR  (H-2 k)  spleen cells. However,  10  X  10  s  to  20 
×  10  s H-2 d spleen cells (10-20  times as many  as H-2 b spleen cells)  were required to 
absorb the total antibody activity. The  D4 antibody gave the same results as the H6 
Fro.  6.  Fluorescence  profiles of the I-jb-positive  T  cell hybridoma (34S-18) with the monoclonal 
anti-I-J  b antibody El0. The T  hybridoma cells pretreated with neuraminidase were reacted with 
(a)  10 pg of the purified El0 antibody (IgG~)  or with (b)  10 pg of the purified myeloma protein 
(CBPC  101:IgG~,) followed by staining with fluorescein-conjugated  rabbit anti-mouse IgG~a anti- 
bodies.  They were compared with T  cell hybridomas stained with fluorescein-conjugated  rabbit 
anti-mouse IgG2, antibodies. Cells thus treated were analyzed by FACS IV with a linear amplifier. KANNO ET AL. 
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FIG.  7.  FACS  analysis of the monoclonal anti-I-J b antibodies El0 and H6 on Con A-induced 
thymocyte blasts from C57BL/6 and C3H mice. Con A-induced thymocyte blasts from C57BL/6 
mice treated with 1 #g of the purified El0 (IgG~) (a) or H6 (IgG~) (b) antibodies were compared 
with those reacted with  1 #g of the  purified CBPC  101  myeloma protein  (IgG~) as a control. 
Similarly, Con A-induced C3H thymocyte blasts reacted with 1 #g of the purified El0 (c) and H6 
(d) antibodies were compared with those treated  with  1 #g of the purified CBPC  101 myeloma 
protein. All cells treated  with  monoclonal antibodies and  myeloma protein  were stained  with 
fluorescein-conjugated rabbit  anti-mouse  IgG,..  Large  blast cells, which  are  -20% of Con  A- 
stimulated thymocytes, were analyzed by FACS IV with a logarithmic amplifier. Note that Con A 
blasts of C57BL/6 (a, b) but not C3H (c, d) were significantly stained by the monoclonal anti-I-J b 
antibodies El0 (a) and H6 (b). 
antibody  (data  not shown).  Table I  summarizes  the results  of the absorption  of the 
monoclonal antibodies  with  spleen  cells  from various  mouse strains,  demonstrating 
that the cytotoxicity of the El0, F4, and D7 antibodies was absorbed only with H-2 b 
spleen cells, whereas that of the H6 and D4 antibodies was absorbed by the H-2 a as 
well as H-2 b spleen cells. From the results in Figs. 3, 4, and 5, it is concluded that the 
D4 and  H6 antibodies  were able  to react  with  I-J  b and  I-J  d products,  whereas  the 
El0, F4, and D7 antibodies reacted only with I-J  b products. 
Absorption of an Antigen-specific Suppressor Factor with Columns Composed of Monoclonal 
Antibodies.  To  determine  whether  the  monoclonal  antibodies  have  the  capacity to 
absorb  the  antigen-specific  suppressor  T  cell  factor,  a  gamma  globulin  fraction  of 
ascites  from  the  hybridoma-bearing  mice  was  coupled  to  the  Sepharose  4B.  The 
KLH-specific monoclonal suppressor factor bearing I-J  b products was absorbed with 
these columns. The absorbed materials to the columns were also eluted with 0.175 M 
glycine HC1 buffer, pH 3.2. The effluent or the eluate  from the columns was tested 
for its suppressor activity in the in vitro secondary antibody response.  The results in 
Table  II  demonstrate  that  the  hybridoma-derived  I-Jb-bearing  factor  significantly 
suppressed the antibody response. The suppressor activity was absorbed to and eluted 
from the columns of monoclonal antibodies El0, F4, D7, D4, and H6. It is suggested 
that  the  determinants  on  antigen-specific  suppressor  T  cells  recognized  by  the 
monoclonal antibodies are also expressed on their soluble antigen-specific suppressor 
factors. 
Immunofluorescent Stainings.  The I-jb-positive T  cell hybridoma (34S-704)  cells and 
Con  A-induced  thymocyte blast  cells  were  reacted  with  purified  monoclonal  anti- 
bodies El0  (IgG2a) and  H6  (IgG~)  followed by staining with fluorescein-conjugated 1300  MONOCLONAL ANTI-I-J ANTIBODIES 
rabbit anti-mouse IgG2a. The same amounts of CBPC  101  myeloma protein (IgG2~) 
were used as a control for immunofluorescent stainings. They were then analyzed by 
FACS IV. The staining profiles of the monoclonal Et0 antibody on the I-Jb-positive 
hybridoma are shown in Fig. 6a with the control stainings shown for comparison. The 
El0  antibody  weakly  but  significantly stained  the  I-jb-positive  hybridoma  cells, 
whereas no staining was observed with CBPC  101  myeloma protein  (IgG2a) having 
the same immunoglobulin subclass as the El0 antibody (Fig. 6b).  The same results 
were also obtained in Fig. 7 by the stainings of Con A-induced thymocyte blasts with 
the monoclonal reagents (El0 and H6). The monoclonal El0 or H6 antibodies stained 
Con A-induced blast cells only from C57BL/6  (Fig.  7 a  and b)  but not from C3H 
mice  (Fig.  7 c  and  d).  No  significant  staining  was  obtained  on  either  normal 
C57BL/6 or C3H thymocytes with these antibodies (data not shown). 
Discussion 
We described the monoclonal antibodies recognizing the product of a gene in the 
I-J subregion of the 14-2 major histocompatibility complex. The monoclonal antibodies 
were produced by hybridomas of NS-1  or P3U 1 myeloma cells lacking the enzyme 
hypoxanthine guanine phosphoribosyl transferase, and spleen cells from B10.A(5R) 
mice repeatedly immunized with mitomycin C-treated  B10.A(3R)  lymphoid cells. 
The combination of B10.A(5R)  and B10.A(3R)  mice is ideal for making antibodies 
specific for the I-J subregion gene product because the only genetic difference between 
B 10.A(5R) and B 10.A(3R) is supposed to be the I-J subregion. Furthermore, an I-J  b- 
positive hybridoma with specific suppressor function was available as a useful target 
cell for selecting monoclonal anti-I-Jb-producing hybridomas. Two groups of hybri- 
domas producing  monoclonal anti-I-J  b antibodies  with  different specificities  have 
been established: one recognizing the private type of the I-J  b determinant, the other 
recognizing the public or cross-reactive determinant on  the I-J  b,  which  is  at  least 
shared by I-J  ° products. 
The specificity of monoclonal antibodies was determined in three different ways. 
First, the antibody activity was tested on the suppressor T  cells of various strains of 
mice by a cytotoxic assay. It has been demonstrated that antigen-specific suppressor 
T  cells enriched by antigen-coated dishes or columns bear the I-J products (13,  14). 
By using the enriched suppressor T  cells, it is clearly demonstrated in Fig. 2 that the 
monoclonal  antibodies  have  the  ability  to  lyse  I-J-bearing  suppressor  T  cells  of 
C57BL/6 but not those of C3H mice. 
Secondly, quantitative absorption analysis with unprimed spleen cells from various 
strains of mice including independent haplotype strains, 1t-2 recombinant, and 14-2 
congenic mice was carried out to define the genetic specificity of monoclonal anti- 
bodies. From these experiments, the monoclonal antibodies were shown to be reactive 
with spleen ceils having I-J b haplotype but not those with I-J ~ and I-J s haplotypes. 
Especially, all monoclonal antibodies tested were not reactive with C3H mice, whereas 
C3H.SW  having H-2 b haplotype with the  same  background  as C3H  (1-1-2  k)  mice 
absorbed the antibody activity. Similarly, the antibody reactivity was always removed 
by absorption of C57BL/10 (H-2 b)  spleen cells but not that of B10.BR  (H-2 k)  and 
B 10.S (H-2 ~) with C57BL/10 background, suggesting that the antibodies are directed 
against H-2 b products. Moreover, the antibodies could be absorbed by spleen cells of KANNO ET AL.  1301 
BI0.A(3R)  but  not B10.A(5R)  mice. Therefore, it seems clear that  the monoclonal 
antibodies established are specific for the I-J  b products. 
The l-J subregion is defined as a chromosomal segment encompassing the Ia-4 locus 
with the cross-over positions in strains B10.A(5R)  and B10.A(3R)  forming regional 
boundaries.  The  recombinants  are  derived  from  a  cross  between  A/WySn  and 
C57BL/10 (reviewed in 23) and carry the chromosomal segment of A/WySn origin, 
which is extended from the intra-H-2 recombinant points to somewhere to the right 
of the H-2D. The extra-Ho2 (right) end of this inserted chromosomal segment is totally 
unknown, and the crossover points at the right end in B10.A(3R) and B10.A(5R) are 
probably not identical. It is thus possible that the immunization in this combination 
gives rise to antibodies not only against the products of genes within the I-J subregion 
but also against those of unknown genes on the right side of the chromosomal segment, 
which  can  be either A/WySn or C57BL/10  type. To exclude this  possibility,  the 
antibodies were tested for their reactivity on spleen cells of B10.A(2R) and A/WySn. 
Recombinant  B10.A(2R), which  arose in  the same  series of the back-crossing that 
produced B10.A(5R)  and B10.A(3R), should have the inherited chromosomal sege- 
ment to the right of the H-2D  from the parental  C57BL/10 mice and the inserted 
chromosome to the left of the H-2S from A/WySn. B10.A(2R)  and A/WySn strains 
are k type at the I-J subregion, and the right side end of the 17th chromosome in these 
mice should represent the respective parental type. Therefore, antibodies to unknown 
products of the right side of the extra-H-2 genes of B 10.A(3R) mice should react with 
one of B 10.A(2R) and A/WySn, whereas anti-I-J  b antibodies should not. As shown in 
Table  I  and  Fig.  4 a  and  b,  none  of the  monoclonal antibodies,  including  cross- 
reactive (H6) and noncross-reactive (El0), was absorbed by B 10.A(2R) or A/WySn 
spleen  cells.  These results  show conclusively that  these  monoclonal antibodies  are 
directed to the products of genes within the 1-.]7 subregion of the H-2 complex. 
Thirdly, our previous studies (3, 8, 22, 24) have demonstrated that various alloan- 
tibodies directed against I-J products have the capacity to absorb the KLH-specific 
suppressor factors from primed splenic T  cells and KLH=specific suppressor hybrido- 
mas.  Similar  observations  have  been  reported  by several  other  investigators  with 
different systems  (reviewed in  2).  Table  II  shows  that  the  monoclonal suppressor 
factor was absorbed to and eluted from the columns of the monoclonal antibodies. 
Thus,  it  is  strongly  suggested  that  the  monoclonal antibodies  described  here  are 
specific for the product of a gene in the I-J subregion of the H-2 complex. 
Some cross-reactivities between I-J  k and  I-J  s products and  between I-J  a and  I-J  k 
products have been reported by Murphy et al. (1) and Frelinger et al. (10), respectively. 
The  results  shown  in  Figs.  2c  and  5b  and  Table  I  clearly  demonstrate  that  the 
monoclonal .D4 and H6 antibodies could react with H-2 a as well as H-2 b spleen cells. 
That the D4 and H6 antibodies were shown to be specific for the I-J  b products (see 
Fig. 4 and Table I) and that they also killed suppressor T  cells enriched from KLH- 
primed  BALB/c  (H-2 a)  spleen  cells  (Fig.  2c),  indicates  that  the  I-J  b determinant 
detected by the monoclonal antibodies H6 and D4 is the cross-reactive determinant 
shared by the  I-J  a products.  It  is  therefore likely that  I-J  products  have both  the 
private and public type determinants, like other Ia molecules controlled by the I-A or 
I-E/C subregion expressed on B cells (reviewed in 12). However, quantitative absorp- 
tion studies showed that 2 ×  107 spleen cells from 1-1-2  a mice, which are  10-20 times 
as much as the 11-2  b spleen cells, are necessary for the complete absorption of the H6 1302  MONOCLONAL ANTI-I-J ANTIBODIES 
and D4 monoclonal antibodies. This is probably due to the lower affinity of the D4 
and H6 monoclonal antibodies for the I-J  a products than that for the I-J  b products. 
No direct demonstration of the/-J-encoded products has so far been reported. By 
using  the  monoclonal  anti-I-J  b  antibodies,  the  results  in  Fig.  7 a  and  b  clearly 
demonstrate that the I-J products were detected on the cell surface of the Con A- 
induced thymocyte blasts from C57BL/6 but not C3H mice. However, no significant 
staining pattern was observed with normal thymocytes from either C57BL/6 or C3H 
mice (data not show). The findings suggest that the stimulation with Con A induces 
a proliferation of I-J-positive cells or the expression of I-J products on the cell surface. 
The antigen-specific suppressor T  cells and their factors have been found to bear 
the determinants detected by conventional anti-I-J alloantisera. There is, however, no 
evidence that I-J determinants on the suppressor T cells and their factors are encoded 
by the same gene. The monoclonal reagents made this problem clear. The monoclonal 
anti-I-J  b antibodies we described detected the determinants on the suppressor T  cell 
hybridoma and on the enriched suppressor T  cells by membrane stainings and/or 
cytotoxic assays. The antibodies also stained Con A-stimulated thymocytes, supporting 
the previous findings reported by Frelinger et al. (10) that Con A-reactive T cells bear 
I-J products. Moreover, the same monoclonal antibody has the capacity to absorb the 
antigen-specific suppressor T  cell factor. From these results (Table II; Figs. 2 and 6) 
it is clear that the product encoded by a gene in the I-J subregion is expressed on both 
suppressor T  cells and their factors. 
Murphy et al. (1) originally determined that the Ia-4 locus controls the determinants 
expressed on the allotype-specific suppressor T  lymphocytes. However, the presence 
of the Ia-4-encoded product on the antigen-specific suppressor T cells and their factors 
has not been formally investigated. The results presented here also have not deter- 
mined whether the monoclonal anti-I-J antibodies recognize the Ia-4 product. 
Cumulative evidence has suggested that two or more genes are accommodated in 
the I-J subregion of the H-2  complex  (9).  2 In  this  respect,  monoclonal antibodies 
against  I-J  products  with  different specificities would  be  useful  in  discriminating 
between the heterogenous I-J products expressed on functionally different lymphocyte 
subsets. Further research, currently in progress, is required to answer these questions. 
Summary 
The B cell hybridomas producing monoelonal antibodies  (El0,  D7, F4, H6, and 
D4)  were established by the fusion of P3U 1 or NS-1  murine myeloma cell lines and 
spleen cells of B 10.A (5R) mice hyperimmunized with mitomycin C-t  reated B 10.A (3R) 
spleen and thymus cells. Two types of monoclonal antibodies specific for the products 
controlled by a gene in the I-J b subregion of the H-2 complex were characterized: one 
specific  for the  private  type of I-J  b determinant,  the  other  recognizing the  cross- 
reactive determinant between the I-J  b and I-J  a products. By using these monoclonal 
reagents, the/-J-encoded product on the antigen-specific suppressor T cells was found 
to be expressed on their soluble suppressor factors. Furthermore, the I-J  b products 
were successfully detected not only on the T  cell hybridoma with suppressor activity 
specific for keyhole limpet hemocyanin (KLH), but also on KLH-primed suppressor 
T  cells enriched by antigen-coated petri dishes and concanavalin A-induced thymo- 
2 Takei, I., T. Saito, K. Hiramatsu, M. Kanno, and M. Taniguchi. Heterogeneity of I-J subregion  gene 
products expressed on functionally different T cell hybridomas. Manuscript in preparation. KANNO ET AL.  1303 
cyte blasts of C57BL/6  mice by complement-dependent  cytotoxic assays and  mem- 
brane fluorescence techniques. 
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